Thanh Dellinger, M.D., is a gynecological oncologist with specialized training in robotic-assisted (minimally-invasive) surgery for uterine and cervical cancer, which can be as effective as traditional surgery but with reduced scarring, pain and recovery time.
Dr. Dellinger is also an expert in advanced cytoreductive surgery for ovarian cancer, which can significantly improve survival outcomes for patients. Additionally, Dr Dellinger is leading a clinical trial in hyperthermic intraperitoneal chemotherapy (NCI-2013-01948), a novel therapy using heated chemotherapy at time of surgery for ovarian cancer.
Dr. Dellinger’s research focus is in ovarian and uterine cancer, and she has co-authored several papers on molecular pathways in ovarian and uterine cancer. Her current research focuses on innovative and novel therapies for ovarian cancer using gene therapy, stem cell and nanoparticle therapies.
Dr. Dellinger received her medical degree at the University of California in Irvine, followed by a residency at Penn State University, and a gynecologic oncology fellowship at the University of California Irvine Medical Center.
Beca de investigación